Which has better valuation & earnings, HQY or ITGR?

HealthEquity has higher earnings, but lower revenue than Integer. Integer is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HealthEquity $1.31B 6.75 $215.20M $2.67 39.72 Integer $1.84B 2.31 $102.81M $3.66 34.25

Is HQY or ITGR more profitable?

HealthEquity has a net margin of 17.25% compared to Integer's net margin of 6.97%. HealthEquity's return on equity of 14.75% beat Integer's return on equity. Company Net Margins Return on Equity Return on Assets HealthEquity 17.25% 14.75% 9.22% Integer 6.97% 12.79% 6.48%

Does the media refer more to HQY or ITGR?

In the previous week, HealthEquity had 4 more articles in the media than Integer. MarketBeat recorded 8 mentions for HealthEquity and 4 mentions for Integer. HealthEquity's average media sentiment score of 1.55 beat Integer's score of 1.17 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Integer 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, HQY or CNC?

HealthEquity has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HealthEquity $1.31B 6.75 $215.20M $2.67 39.72 Centene $194.78B 0.16 -$6.67B -$10.44 N/A

Is HQY or CNC more profitable?

HealthEquity has a net margin of 17.25% compared to Centene's net margin of -2.51%. HealthEquity's return on equity of 14.75% beat Centene's return on equity. Company Net Margins Return on Equity Return on Assets HealthEquity 17.25% 14.75% 9.22% Centene -2.51% 12.12% 3.20%

Does the media refer more to HQY or CNC?

In the previous week, Centene had 20 more articles in the media than HealthEquity. MarketBeat recorded 28 mentions for Centene and 8 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.55 beat Centene's score of 1.04 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Centene 19 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to HQY or MOH?

In the previous week, Molina Healthcare had 11 more articles in the media than HealthEquity. MarketBeat recorded 19 mentions for Molina Healthcare and 8 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.55 beat Molina Healthcare's score of 0.78 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Molina Healthcare 6 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer HQY or OSCR?

In the previous week, Oscar Health had 2 more articles in the media than HealthEquity. MarketBeat recorded 10 mentions for Oscar Health and 8 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.55 beat Oscar Health's score of 1.11 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Oscar Health 5 Very Positive mention(s) 4 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ALHC or HQY?

In the previous week, Alignment Healthcare had 7 more articles in the media than HealthEquity. MarketBeat recorded 15 mentions for Alignment Healthcare and 8 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.55 beat Alignment Healthcare's score of 0.11 indicating that HealthEquity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alignment Healthcare 4 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 4 Very Negative mention(s) Neutral HealthEquity 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

HealthEquity (HQY) Competitors

$106.04 +2.09 (+2.01%)

As of 12:10 PM Eastern

Compare

HQY vs. ITGR, CNC, MOH, OSCR, and ALHC

Should you buy HealthEquity stock or one of its competitors? HealthEquity's main competitors and comparable companies include Integer (ITGR), Centene (CNC), Molina Healthcare (MOH), Oscar Health (OSCR), and Alignment Healthcare (ALHC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does HealthEquity compare to Integer?

HealthEquity (NASDAQ:HQY) and Integer (NYSE:ITGR) are both mid-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

HealthEquity presently has a consensus price target of $110.93, indicating a potential upside of 4.61%. Integer has a consensus price target of $109.86, indicating a potential downside of 12.36%. Given HealthEquity's stronger consensus rating and higher possible upside, research analysts plainly believe HealthEquity is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07

In the previous week, HealthEquity had 4 more articles in the media than Integer. MarketBeat recorded 8 mentions for HealthEquity and 4 mentions for Integer. HealthEquity's average media sentiment score of 1.55 beat Integer's score of 1.17 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Integer	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has a beta of 0.21, meaning that its share price is 79% less volatile than the broader market. Comparatively, Integer has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market.

HealthEquity has a net margin of 17.25% compared to Integer's net margin of 6.97%. HealthEquity's return on equity of 14.75% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Integer	6.97%	12.79%	6.48%

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by company insiders. Comparatively, 1.1% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

HealthEquity has higher earnings, but lower revenue than Integer. Integer is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	6.75	$215.20M	$2.67	39.72
Integer	$1.84B	2.31	$102.81M	$3.66	34.25

Summary

HealthEquity beats Integer on 13 of the 16 factors compared between the two stocks.

How does HealthEquity compare to Centene?

HealthEquity (NASDAQ:HQY) and Centene (NYSE:CNC) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

HealthEquity has a net margin of 17.25% compared to Centene's net margin of -2.51%. HealthEquity's return on equity of 14.75% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Centene	-2.51%	12.12%	3.20%

HealthEquity has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	6.75	$215.20M	$2.67	39.72
Centene	$194.78B	0.16	-$6.67B	-$10.44	N/A

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 1.6% of HealthEquity shares are held by company insiders. Comparatively, 0.4% of Centene shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

HealthEquity presently has a consensus price target of $110.93, indicating a potential upside of 4.61%. Centene has a consensus price target of $70.05, indicating a potential upside of 8.91%. Given Centene's higher probable upside, analysts clearly believe Centene is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77
Centene	2 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.40

In the previous week, Centene had 20 more articles in the media than HealthEquity. MarketBeat recorded 28 mentions for Centene and 8 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.55 beat Centene's score of 1.04 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Centene	19 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has a beta of 0.21, meaning that its share price is 79% less volatile than the broader market. Comparatively, Centene has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market.

Summary

HealthEquity beats Centene on 12 of the 17 factors compared between the two stocks.

How does HealthEquity compare to Molina Healthcare?

HealthEquity (NASDAQ:HQY) and Molina Healthcare (NYSE:MOH) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations and media sentiment.

In the previous week, Molina Healthcare had 11 more articles in the media than HealthEquity. MarketBeat recorded 19 mentions for Molina Healthcare and 8 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.55 beat Molina Healthcare's score of 0.78 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Molina Healthcare	6 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by company insiders. Comparatively, 1.4% of Molina Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Molina Healthcare has higher revenue and earnings than HealthEquity. Molina Healthcare is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	6.75	$215.20M	$2.67	39.72
Molina Healthcare	$45.43B	0.23	$472M	-$0.18	N/A

HealthEquity has a beta of 0.21, meaning that its stock price is 79% less volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.75, meaning that its stock price is 25% less volatile than the broader market.

HealthEquity currently has a consensus price target of $110.93, suggesting a potential upside of 4.61%. Molina Healthcare has a consensus price target of $202.44, suggesting a potential upside of 0.91%. Given HealthEquity's stronger consensus rating and higher probable upside, research analysts clearly believe HealthEquity is more favorable than Molina Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77
Molina Healthcare	2 Sell rating(s)	11 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.18

HealthEquity has a net margin of 17.25% compared to Molina Healthcare's net margin of -0.02%. HealthEquity's return on equity of 14.75% beat Molina Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Molina Healthcare	-0.02%	3.73%	0.97%

Summary

HealthEquity beats Molina Healthcare on 12 of the 17 factors compared between the two stocks.

How does HealthEquity compare to Oscar Health?

HealthEquity (NASDAQ:HQY) and Oscar Health (NYSE:OSCR) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and media sentiment.

HealthEquity has a net margin of 17.25% compared to Oscar Health's net margin of 3.60%. Oscar Health's return on equity of 38.45% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Oscar Health	3.60%	38.45%	6.76%

In the previous week, Oscar Health had 2 more articles in the media than HealthEquity. MarketBeat recorded 10 mentions for Oscar Health and 8 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.55 beat Oscar Health's score of 1.11 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Oscar Health	5 Very Positive mention(s)	4 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has a beta of 0.21, indicating that its share price is 79% less volatile than the broader market. Comparatively, Oscar Health has a beta of 2.36, indicating that its share price is 136% more volatile than the broader market.

HealthEquity currently has a consensus target price of $110.93, suggesting a potential upside of 4.61%. Oscar Health has a consensus target price of $26.22, suggesting a potential downside of 20.97%. Given HealthEquity's stronger consensus rating and higher possible upside, equities research analysts clearly believe HealthEquity is more favorable than Oscar Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77
Oscar Health	0 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.42

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 75.7% of Oscar Health shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by company insiders. Comparatively, 22.6% of Oscar Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

HealthEquity has higher earnings, but lower revenue than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	6.75	$215.20M	$2.67	39.72
Oscar Health	$11.70B	0.88	-$443.15M	$1.40	23.70

Summary

HealthEquity beats Oscar Health on 11 of the 17 factors compared between the two stocks.

How does HealthEquity compare to Alignment Healthcare?

Alignment Healthcare (NASDAQ:ALHC) and HealthEquity (NASDAQ:HQY) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Alignment Healthcare has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market. Comparatively, HealthEquity has a beta of 0.21, suggesting that its stock price is 79% less volatile than the broader market.

HealthEquity has lower revenue, but higher earnings than Alignment Healthcare. HealthEquity is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alignment Healthcare	$3.95B	0.69	-$720K	$0.19	68.95
HealthEquity	$1.31B	6.75	$215.20M	$2.67	39.72

86.2% of Alignment Healthcare shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 5.2% of Alignment Healthcare shares are owned by company insiders. Comparatively, 1.6% of HealthEquity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Alignment Healthcare had 7 more articles in the media than HealthEquity. MarketBeat recorded 15 mentions for Alignment Healthcare and 8 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.55 beat Alignment Healthcare's score of 0.11 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alignment Healthcare	4 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	4 Very Negative mention(s)	Neutral
HealthEquity	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

HealthEquity has a net margin of 17.25% compared to Alignment Healthcare's net margin of 0.89%. Alignment Healthcare's return on equity of 20.02% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alignment Healthcare	0.89%	20.02%	3.46%
HealthEquity	17.25%	14.75%	9.22%

Alignment Healthcare currently has a consensus price target of $23.60, suggesting a potential upside of 80.15%. HealthEquity has a consensus price target of $110.93, suggesting a potential upside of 4.61%. Given Alignment Healthcare's higher probable upside, research analysts clearly believe Alignment Healthcare is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alignment Healthcare	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.64
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77

Summary

HealthEquity beats Alignment Healthcare on 9 of the 16 factors compared between the two stocks.

Get HealthEquity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HQY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HQY vs. The Competition

Export

Metric	HealthEquity	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$8.86B	$9.77B	$7.30B	$12.73B
Dividend Yield	N/A	2.54%	2.55%	10.29%
P/E Ratio	39.72	35.52	269.19	24.07
Price / Sales	6.75	4.94	623.49	97.60
Price / Cash	19.48	126.93	78.23	52.73
Price / Book	4.30	4.00	13.07	6.19
Net Income	$215.20M	$311.06M	$3.46B	$347.71M
7 Day Performance	0.43%	-0.09%	1.61%	-0.65%
1 Month Performance	7.24%	0.36%	4.76%	2.11%
1 Year Performance	19.09%	17.22%	27.96%	20.11%

HealthEquity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HQY HealthEquity	4.063 of 5 stars	$106.04 +2.0%	$110.93 +4.6%	+15.6%	$8.86B	$1.31B	39.72	2,814	Upcoming Earnings
ITGR Integer	2.5894 of 5 stars	$125.10 -0.1%	$109.86 -12.2%	+17.8%	$4.26B	$1.85B	34.18	11,000	Positive News
CNC Centene	3.8669 of 5 stars	$66.51 +1.1%	$68.58 +3.1%	+120.6%	$32.49B	$194.78B	N/A	61,100	Analyst Forecast Insider Trade
MOH Molina Healthcare	2.5459 of 5 stars	$198.90 +1.2%	$202.44 +1.8%	+16.0%	$10.25B	$45.43B	N/A	19,000	Positive News
OSCR Oscar Health	4.3644 of 5 stars	$27.71 -0.7%	$24.00 -13.4%	+94.3%	$8.41B	$11.70B	19.79	2,305	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HQY) was last updated on 8/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HealthEquity (HQY) Competitors

HQY vs. ITGR, CNC, MOH, OSCR, and ALHC

How does HealthEquity compare to Integer?

Summary

How does HealthEquity compare to Centene?

Summary

How does HealthEquity compare to Molina Healthcare?

Summary

How does HealthEquity compare to Oscar Health?

Summary

How does HealthEquity compare to Alignment Healthcare?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQY vs. The Competition

HealthEquity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HealthEquity (HQY) Competitors

HQY vs. ITGR, CNC, MOH, OSCR, and ALHC

How does HealthEquity compare to Integer?

Do analysts prefer HQY or ITGR?

Does the media refer more to HQY or ITGR?

Which has more risk and volatility, HQY or ITGR?

Is HQY or ITGR more profitable?

Do insiders & institutionals believe in HQY or ITGR?

Which has better valuation & earnings, HQY or ITGR?

Summary

How does HealthEquity compare to Centene?

Is HQY or CNC more profitable?

Which has higher valuation and earnings, HQY or CNC?

Do insiders and institutionals hold more shares of HQY or CNC?

Do analysts rate HQY or CNC?

Does the media refer more to HQY or CNC?

Which has more risk and volatility, HQY or CNC?

Summary

How does HealthEquity compare to Molina Healthcare?

Does the media refer more to HQY or MOH?

Do insiders & institutionals have more ownership in HQY or MOH?

Which has stronger valuation and earnings, HQY or MOH?

Which has more risk & volatility, HQY or MOH?

Do analysts rate HQY or MOH?

Is HQY or MOH more profitable?

Summary

How does HealthEquity compare to Oscar Health?

Is HQY or OSCR more profitable?

Does the media prefer HQY or OSCR?

Which has more volatility & risk, HQY or OSCR?

Do analysts rate HQY or OSCR?

Do insiders & institutionals have more ownership in HQY or OSCR?

Which has better earnings and valuation, HQY or OSCR?

Summary

How does HealthEquity compare to Alignment Healthcare?

Which has more volatility & risk, ALHC or HQY?

Which has better earnings & valuation, ALHC or HQY?

Do institutionals & insiders hold more shares of ALHC or HQY?

Does the media prefer ALHC or HQY?

Is ALHC or HQY more profitable?

Do analysts rate ALHC or HQY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQY vs. The Competition

HealthEquity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools